check_circleStudy Completed

Hypertension, Pulmonary

Bayer Identifier:
18515
ClinicalTrials.gov Identifier:
NCT02576002
EudraCT Number:
Not Available
EU CT Number:
Not Available
Epidemiology and treatment patterns of paediatric PAH (Pulmonary arterial hypertension)

Trial purpose

To describe the prevalence, incidence and current treatment and procedures patterns in a US pediatric population with PAH in MarketScan database during the period 2010-2013

Key Participants Requirements

Sex

Both

Age

NaN - 18 Years
    - All PAH patients who were in the MarketScan database and who were under age 18 at some time during the years 2010 through 2013
    Not applicable

Trial summary

Enrollment Goal
2691
Trial Dates
October 2015 - January 2016
Phase
N/A
Could I Receive a placebo
No
Products
Unspecified
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Boston, United States

Primary Outcome

  • Incidence rate of PAH (pulmonary arterial hypertension)
    date_rangeTime Frame:
    Retrospective analysis of three year period
    enhanced_encryption
    Safety Issue:
    No
  • Prevalence rate of PAH
    date_rangeTime Frame:
    Retrospective analysis of three year period
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • Assigned drug treatment for PAH measured using the MarketScan database
    Description of pulmonary hypertension-targeted drugs prescribed in the study population and changes during the study period
    date_rangeTime Frame:
    Retrospective analysis of three year period
    enhanced_encryption
    Safety Issue:
    No
  • Diagnostic procedures performed among PAH patients measured using the MarketScan database
    date_rangeTime Frame:
    Retrospective analysis of three year period
    enhanced_encryption
    Safety Issue:
    No
  • Prevalence of comorbidities among PAH patients
    date_rangeTime Frame:
    Retrospective analysis of three year period
    enhanced_encryption
    Safety Issue:
    No

Trial design

Study to Estimate the Incidence and Prevalence and treatment patterns of Pediatric Pulmonary Hypertension in the US
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.